Skip to main content
SpringerLink
Log in

Hylan G-F 20 good value for treatment of knee and hip OA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study received unconditional funding from Sanofi Italia.

Reference

  • Migliore A, et al. Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis. ClinicoEconomics and Outcomes Research : 22 Jul 2019. Available from: URL: https://doi.org/10.2147/CEOR.S194669

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hylan G-F 20 good value for treatment of knee and hip OA. PharmacoEcon Outcomes News 834, 21 (2019). https://doi.org/10.1007/s40274-019-6121-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6121-1

Search

Navigation